65 related articles for article (PubMed ID: 34182491)
1. Human Hematopoietic Stem Cell Engrafted IL-15 Transgenic NSG Mice Support Robust NK Cell Responses and Sustained HIV-1 Infection.
Abeynaike SA; Huynh TR; Mehmood A; Kim T; Frank K; Gao K; Zalfa C; Gandarilla A; Shultz L; Paust S
Viruses; 2023 Jan; 15(2):. PubMed ID: 36851579
[TBL] [Abstract][Full Text] [Related]
2. Development of a new humanized mouse model to study acute inflammatory arthritis.
Misharin AV; Haines GK; Rose S; Gierut AK; Hotchkiss RS; Perlman H
J Transl Med; 2012 Sep; 10():190. PubMed ID: 22974474
[TBL] [Abstract][Full Text] [Related]
3. A Monocytic Barrier to the Humanization of Immunodeficient Mice.
Du E; Muench M
Curr Stem Cell Res Ther; 2023 Oct; ():. PubMed ID: 37859310
[TBL] [Abstract][Full Text] [Related]
4. Human IL-6 fosters long-term engraftment of patient derived disease-driving myeloma cells in immunodeficient mice.
Hasanali ZS; Garfall AL; Burzenski L; Shultz LD; Tang Y; Kadu S; Sheppard NC; Liu W; Dopkin D; Vogl DT; Cohen AD; Waxman AJ; Susanibar-Adaniya SP; Carroll M; Stadtmauer EA; Allman D
JCI Insight; 2024 May; ():. PubMed ID: 38713510
[TBL] [Abstract][Full Text] [Related]
5. A Humanized Bone Niche Model Reveals Bone Tissue Preservation Upon Targeting Mitochondrial Complex I in Pseudo-Orthotopic Osteosarcoma.
Kurelac I; Abarrategi A; Ragazzi M; Iommarini L; Umesh Ganesh N; Snoeks T; Bonnet D; Porcelli AM; Malanchi I; Gasparre G
J Clin Med; 2019 Dec; 8(12):. PubMed ID: 31835761
[TBL] [Abstract][Full Text] [Related]
6. Animal model considerations for chordoma research: reproducing the tumor microenvironment
Campilan B; Schroeder C; Sagaityte E; Arditi J; Leary OP; Gokaslan ZL; Sullivan PLZ; Martinez-Moreno M
Front Oncol; 2024; 14():1330254. PubMed ID: 38544830
[TBL] [Abstract][Full Text] [Related]
7. Potential Pitfalls of the Humanized Mice in Modeling Sepsis.
Laudanski K; Stentz M; DiMeglio M; Furey W; Steinberg T; Patel A
Int J Inflam; 2018; 2018():6563454. PubMed ID: 30245803
[TBL] [Abstract][Full Text] [Related]
8. PTPRC Inhibits Ferroptosis of Osteosarcoma Cells via Blocking TFEB/FTH1 Signaling.
Shao Y; Zuo X
Mol Biotechnol; 2023 Oct; ():. PubMed ID: 37851191
[TBL] [Abstract][Full Text] [Related]
9. The Adaptation Model of Immunity: Signal IV Matters Most in Determining the Functional Outcomes of Immune Responses.
Manjili MH
J Immunol; 2023 Mar; 210(5):521-530. PubMed ID: 36881868
[TBL] [Abstract][Full Text] [Related]
10. The adaptation model of immunity: Is the goal of central tolerance to eliminate defective T cells or self-reactive T cells?
Manjili MH
Scand J Immunol; 2022 Oct; 96(4):e13209. PubMed ID: 36239215
[TBL] [Abstract][Full Text] [Related]
11. Establishment of Humanized Mice from Peripheral Blood Mononuclear Cells or Cord Blood CD34+ Hematopoietic Stem Cells for Immune-Oncology Studies Evaluating New Therapeutic Agents.
Verma B; Wesa A
Curr Protoc Pharmacol; 2020 Jun; 89(1):e77. PubMed ID: 32453514
[TBL] [Abstract][Full Text] [Related]
12. A humanized orthotopic mouse model for preclinical evaluation of immunotherapy in Ewing sarcoma.
Luo W; Hoang H; Liao Y; Pan J; Ayello J; Cairo MS
Front Immunol; 2023; 14():1277987. PubMed ID: 37868989
[TBL] [Abstract][Full Text] [Related]
13. Humanized mice are precious tools for evaluation of hematopoietic gene therapies and preclinical modeling to move towards a clinical trial.
Brendel C; Rio P; Verhoeyen E
Biochem Pharmacol; 2020 Apr; 174():113711. PubMed ID: 31726047
[TBL] [Abstract][Full Text] [Related]
14. T Lymphocyte Development and Activation in Humanized Mouse Model.
Lee JY; Han AR; Lee DR
Dev Reprod; 2019 Jun; 23(2):79-92. PubMed ID: 31321348
[TBL] [Abstract][Full Text] [Related]
15. Development of a Bioluminescent Human Osteosarcoma Model in Humanized NSG Mice: A Pilot Study.
Ko Y; Jeong YH; Seo JH; Lee JA
In Vivo; 2021; 35(4):2151-2157. PubMed ID: 34182491
[TBL] [Abstract][Full Text] [Related]
16. Establishment and characterization of in vivo orthotopic bioluminescent xenograft models from human osteosarcoma cell lines in Swiss nude and NSG mice.
Marques da Costa ME; Daudigeos-Dubus E; Gomez-Brouchet A; Bawa O; Rouffiac V; Serra M; Scotlandi K; Santos C; Geoerger B; Gaspar N
Cancer Med; 2018 Mar; 7(3):665-676. PubMed ID: 29473324
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
